Impact of wireless link delay on handover latency in Mobile IPv6 environment.

Autor: Tripathi, Aran Kumar, Radhakrishanan, R., Lather, J.S.

Publikováno v: 2014 International Conference on Issues & Challenges in Intelligent Computing Techniques (ICICT); 01/01/2014, p424-428, 5p

Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model

Autor: Irfana Muqbil, Mahmoud Chaker, Amro Aboukameel, Ramzi M. Mohammad, Asfar S. Azmi, Radhakrishanan Ramchandren

Publikováno v: Heliyon, Vol 5, Iss 8, Pp e02290- (2019)

Bruton's Tyrosine Kinase (BTK) is a member of the TEC family and plays a central role in B-cell signaling, activation, proliferation and differentiation. Here we evaluated the impact of BTK inhibitor Ibrutinib on a panel of HL models in vitro and in

Externí odkaz: https://doaj.org/article/b8d409bca9604bfd9934100210309533

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.

Autor: Seymour EK; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Khan HY; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Li Y; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Chaker M; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Muqbil I; Department of Chemistry, University of Detroit Mercy, Detroit, Michigan., Aboukameel A; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Ramchandren R; Department of Oncology, University of Tennessee, Knoxville, Tennessee., Houde C; Karmanos Cancer Institute, Detroit, Michigan., Sterbis G; Karmanos Cancer Institute, Detroit, Michigan., Yang J; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Bhutani D; Department of Oncology, Columbia University, New York, New York., Pregja S; Karmanos Cancer Institute, Detroit, Michigan., Reichel K; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Huddlestun A; Karmanos Cancer Institute, Detroit, Michigan., Neveux C; Karmanos Cancer Institute, Detroit, Michigan., Corona K; Karyopharm Therapeutics Inc., Newton, Massachusetts., Landesman Y; Karyopharm Therapeutics Inc., Newton, Massachusetts., Shah J; Karyopharm Therapeutics Inc., Newton, Massachusetts., Kauffman M; Karyopharm Therapeutics Inc., Newton, Massachusetts., Shacham S; Karyopharm Therapeutics Inc., Newton, Massachusetts., Mohammad RM; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan., Azmi AS; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. zonderj@karmanos.org azmia@karmanos.org., Zonder JA; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan. zonderj@karmanos.org azmia@karmanos.org.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jun 15; Vol. 27 (12), pp. 3307-3316. Date of Electronic Publication: 2021 Mar 30.

Good news for Kerala.

Autor: Gupta PN; Medical College Hospital, Trivandrum, Kerala 695011, India. Electronic address: ninigupta@gmail.com., Mullamalla UR; Medical College Hospital, Trivandrum, Kerala 695011, India., Koshy AG; Medical College Hospital, Trivandrum, Kerala 695011, India., Kunjukrishanpillai S; Medical College Hospital, Trivandrum, Kerala 695011, India., Vellikat Velayudhan R; Medical College Hospital, Trivandrum, Kerala 695011, India.

Publikováno v: Indian heart journal [Indian Heart J] 2016 Nov - Dec; Vol. 68 (6), pp. 866-867. Date of Electronic Publication: 2016 Jun 29.